Medication Review: Aspirin Already Present—Add PPI for GI Protection
You are already taking aspirin 81 mg daily, which is appropriate for your coronary artery disease, so no additional aspirin is needed. However, you should add a proton pump inhibitor (PPI) because you are on combination antithrombotic therapy (aspirin plus rivaroxaban), which places you at high risk for gastrointestinal bleeding. 1
Critical Issue: Dual Antithrombotic Therapy Requires GI Protection
Your regimen includes both aspirin 81 mg and rivaroxaban (Xarelto) 20 mg, which constitutes combination antithrombotic therapy. The 2019 ESC guidelines explicitly state: "Proton pump inhibitors are recommended in patients receiving aspirin or combination antithrombotic therapy who are at high risk of gastrointestinal bleeding." 1 This is a Class I recommendation—the highest level of evidence-based guidance.
Start a PPI immediately (omeprazole 20 mg daily, lansoprazole 30 mg daily, or pantoprazole 40 mg daily are all appropriate options). The combination of an antiplatelet agent (aspirin) plus an anticoagulant (rivaroxaban) dramatically increases bleeding risk, and PPIs reduce this risk without compromising cardiovascular efficacy 1.
Aspirin Dosing: Already Optimal
Your current aspirin 81 mg daily is the correct dose for secondary prevention in coronary artery disease. Multiple guidelines confirm:
- AHA/ACCF 2011: "Aspirin 75–162 mg daily is recommended in all patients with coronary artery disease" 2
- After PCI, it is reasonable to use 81 mg of aspirin per day in preference to higher maintenance doses 2
- 2016 ACC/AHA: "A daily aspirin dose of 81 mg (range, 75 mg to 100 mg) is recommended" in patients on dual antiplatelet therapy 3
Do not increase the aspirin dose. Higher doses (162–325 mg) increase bleeding risk without improving efficacy 2, 3. Your 81 mg dose provides maximal platelet inhibition with minimal toxicity 4.
Other Medication Concerns
1. Atorvastatin Dosing: Needs Correction
Your atorvastatin 40 mg three times weekly is non-standard and likely suboptimal. Statins should be dosed daily for consistent LDL-lowering and plaque stabilization 5. The FDA label states: "Take orally once daily with or without food" 5.
Change to atorvastatin 40 mg once daily. If cost or side effects are concerns, consider switching to atorvastatin 20 mg daily or rosuvastatin 10 mg daily, both taken every day. Intermittent dosing reduces efficacy and increases LDL variability, which may worsen cardiovascular outcomes.
2. Ranolazine Dosing: Verify Appropriateness
Your ranolazine 500 mg twice daily is the starting dose 6. The FDA label states: "500 mg twice daily and increase to 1000 mg twice daily, based on clinical symptoms" 6.
If you continue to have angina symptoms, discuss increasing to 1000 mg twice daily with your cardiologist. If your angina is well-controlled on 500 mg twice daily, this dose is acceptable, but most patients require the higher dose for optimal symptom relief.
3. Isosorbide Mononitrate: Ensure Nitrate-Free Interval
Your isosorbide mononitrate ER 60 mg daily is appropriate for chronic stable angina. However, long-acting nitrates require a daily nitrate-free interval of 10–14 hours to prevent tolerance 1.
Take this medication in the morning upon waking (as you likely already do). Do not take it at bedtime, as this eliminates the nitrate-free interval and causes loss of efficacy 1.
Summary of Recommendations
| Medication | Current Regimen | Recommended Change | Rationale |
|---|---|---|---|
| Aspirin | 81 mg daily | Continue as is | Optimal dose for CAD; already present [2,3] |
| PPI | None | Add omeprazole 20 mg daily (or equivalent) | Required for GI protection with aspirin + rivaroxaban [1] |
| Atorvastatin | 40 mg 3×/week | Change to 40 mg once daily | Statins must be dosed daily for efficacy [5] |
| Ranolazine | 500 mg twice daily | Consider increasing to 1000 mg twice daily if symptomatic | Standard maintenance dose is 1000 mg BID [6] |
| Isosorbide mononitrate | 60 mg daily | Confirm morning dosing | Requires 10–14 hour nitrate-free interval [1] |
| All other medications | As listed | Continue as prescribed | Appropriate for your conditions |
Key Pitfalls to Avoid
Do not skip the PPI. Combination aspirin + rivaroxaban without GI protection is associated with a 2–3% annual risk of major bleeding 7. PPIs reduce this risk by approximately 50%.
Do not take atorvastatin intermittently. This is not evidence-based and reduces LDL-lowering efficacy. If tolerability is an issue, switch to a different statin or lower daily dose—never use intermittent dosing.
Do not take isosorbide mononitrate at bedtime. This causes nitrate tolerance and loss of anti-anginal effect within days 1.
Monitor for bleeding. With aspirin + rivaroxaban, watch for signs of GI bleeding (black stools, coffee-ground emesis), easy bruising, or prolonged bleeding from minor cuts. Report these immediately.
Why This Matters for Your Outcomes
Your medication regimen targets mortality, morbidity, and quality of life in coronary artery disease:
- Aspirin + rivaroxaban reduce recurrent MI, stroke, and cardiovascular death but increase bleeding risk 8, 7
- PPI addition mitigates bleeding risk without compromising cardiovascular benefit 1
- Daily statin therapy reduces plaque progression, MI, and death 5, 9
- Optimized anti-anginal therapy (ranolazine, isosorbide, metoprolol) improves symptoms and exercise tolerance 1, 6, 10
The single most important change is adding a PPI. This is a Class I, Level A recommendation for your specific combination of medications 1.